July 23 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O:
ANEBULO PHARMACEUTICALS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON STOCK
ANEBULO PHARMACEUTICALS INC - APPROVES REVERSE STOCK SPLIT RATIO BETWEEN 1-FOR-2,500 AND 1-FOR-7,500
ANEBULO PHARMACEUTICALS INC - STOCKHOLDERS TO RECEIVE $3.50 PER PRE-SPLIT SHARE
Source text: ID:nBw2Kqnx7a
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.